Exact Mass: 295.1338982

Exact Mass Matches: 295.1338982

Found 110 metabolites which its exact mass value is equals to given mass value 295.1338982, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Sumatriptan

1-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulphonamide

C14H21N3O2S (295.13544060000004)


Oftentimes, serotonin levels in the brain become extremely erratic before the onset of a migraine. In an attempt to stabilize this, sumatriptan is administered to help aid in leveling the serotonin levels in the brain. Sumatriptan is structurally similar to serotonin, and is a 5-HT (5-HT1D) agonist, which is one of the receptors that serotonin binds to. The specific receptor subtype it activates is present in the cranial and basilar arteries. Activation of these receptors causes vasoconstriction of those dilated arteries. Sumatriptan is also shown to decrease the activity of the trigeminal nerve. Sumatriptan is a triptan drug including a sulfonamide group structurally similar to serotonin, and is a 5-HT (5-HT1D) agonist, which is one of the receptors that serotonin binds to. Oftentimes, serotonin levels in the brain become extremely erratic before the onset of a migraine. In an attempt to stabilize this, sumatriptan is administered to help aid in leveling the serotonin levels in the brain. A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of migraines. Sumatriptan (Imitrex, Imigran, Imigran Recovery) is a triptan drug including a sulfonamide group which was originally developed by Glaxo for the treatment of migraine headaches. Oftentimes, serotonin levels in the brain become extremely erratic before the onset of a migraine. In an attempt to stabilize this, sumatriptan is administered to help aid in leveling the serotonin levels in the brain. Sumatriptan is structurally similar to serotonin, and is a 5-HT (5-HT1D) agonist, which is one of the receptors that serotonin binds to. The specific receptor subtype it activates is present in the cranial and basilar arteries. Activation of these receptors causes vasoconstriction of those dilated arteries. Sumatriptan is also shown to decrease the activity of the trigeminal nerve.; Sumatriptan is a triptan drug including a sulfonamide group structurally similar to serotonin, and is a 5-HT (5-HT1D) agonist, which is one of the receptors that serotonin binds to. N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Sumatriptan (GR 43175) is an orally active 5-HT1 receptor agonist with IC50s of 7.3 nm, 9.3nm and 17.8 nm for 5-HT1D, 5-HT1B and 5-HT1F receptors, respectively. Sumatriptan can be used for migraine headache research[1][2][3][4].

   

NSC627046

N6,N6-Dimethyladenosine

C12H17N5O4 (295.1280482)


N6,N6-Dimethyladenosine is a modified ribonucleoside previously found in rRNA, and also exhibits in mycobacterium bovis Bacille Calmette-Guérin tRNA[1].

   

GYKI 52895

4-(8-METHYL-8,9-DIHYDRO-7H-[1,3]DIOXOLO[4,5:4,5]BENZO[1,2-D][1,2]DIAZEPIN-5-YL)ANILINE

C17H17N3O2 (295.1320702)


   

Dothiepin

dimethyl(3-{9-thiatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene}propyl)amine

C19H21NS (295.13946260000006)


   

N(6),O(2)-Dimethyladenosine

2-(hydroxymethyl)-4-methoxy-5-[6-(methylamino)-9H-purin-9-yl]oxolan-3-ol

C12H17N5O4 (295.1280482)


   

N2-Ethyl-2'-deoxyguanosine

2-(ethylamino)-9-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one

C12H17N5O4 (295.1280482)


   

Pizotifen

1-methyl-4-{6-thiatricyclo[8.4.0.0³,⁷]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene}piperidine

C19H21NS (295.13946260000006)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D002491 - Central Nervous System Agents > D000700 - Analgesics Pizotifen (Pizotyline) is a potent 5-HT2 receptor antagonist, with a high affinity for 5-HT1C binding site.

   

N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide

N-(oxo-5,6-Dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride

C17H17N3O2 (295.1320702)


   
   

2-O-beta-D-glucopyranosyl 1,4-Dideoxy-1,4-imino-D-arabinitol

1,4-Dideoxy-1,4-imino-(2-O-beta-D-glucopyranosyl)-D-arabinitol

C11H21NO8 (295.1267106)


   

Pethoxamid

Pethoxamide

C16H22ClNO2 (295.1338982)


CONFIDENCE standard compound; INTERNAL_ID 2535 CONFIDENCE standard compound; INTERNAL_ID 8399 CONFIDENCE standard compound; INTERNAL_ID 4062 CONFIDENCE standard compound; EAWAG_UCHEM_ID 700

   

Dothiepin

(E)-Dosulepin

C19H21NS (295.13946260000006)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu); Flow Injection Flow Injection; CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu)

   

N-benzyl-N-(1-cyclopropylethenyl)-3-fluorobenzamide

N-benzyl-N-(1-cyclopropylethenyl)-3-fluorobenzamide

C19H18FNO (295.13723500000003)


   

Pizotifen

Pizotyline

C19H21NS (295.13946260000006)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D002491 - Central Nervous System Agents > D000700 - Analgesics Pizotifen (Pizotyline) is a potent 5-HT2 receptor antagonist, with a high affinity for 5-HT1C binding site.

   

12-hydroxy-(13betaH)-19,20-dinor-crotalanane-11,15-dione|Crobarbatin|crobarbatine

12-hydroxy-(13betaH)-19,20-dinor-crotalanane-11,15-dione|Crobarbatin|crobarbatine

C15H21NO5 (295.1419656)


   

5-acetamido-3,5-dideoxy-beta-D-glycero-D-galacto-nonulopyranose|5-Acetamido-3,5-dideoxy-D-glycero-beta-D-galacto-nonulo-pyranose

5-acetamido-3,5-dideoxy-beta-D-glycero-D-galacto-nonulopyranose|5-Acetamido-3,5-dideoxy-D-glycero-beta-D-galacto-nonulo-pyranose

C11H21NO8 (295.1267106)


   

1,4-dideoxy-1,4-imino-(5-O-beta-D-glucopyranosyl)-D-arabinitol

1,4-dideoxy-1,4-imino-(5-O-beta-D-glucopyranosyl)-D-arabinitol

C11H21NO8 (295.1267106)


   

6N-Me-2-Methyladenosine

6N-Me-2-Methyladenosine

C12H17N5O4 (295.1280482)


   
   

N-coronafacoyl-L-serine

N-coronafacoyl-L-serine

C15H21NO5 (295.1419656)


   

Propranolol HCl

Propranolol hydrochloride

C16H22ClNO2 (295.1338982)


Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3]. Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3]. Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3].

   

C15H21NO5

NCGC00385487-01_C15H21NO5_

C15H21NO5 (295.1419656)


   

sumatriptan

sumatriptan

C14H21N3O2S (295.13544060000004)


N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations > N02CC - Selective serotonin (5ht1) agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Sumatriptan (GR 43175) is an orally active 5-HT1 receptor agonist with IC50s of 7.3 nm, 9.3nm and 17.8 nm for 5-HT1D, 5-HT1B and 5-HT1F receptors, respectively. Sumatriptan can be used for migraine headache research[1][2][3][4].

   

Dosulepin

(E)-Dosulepin

C19H21NS (295.13946260000006)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu)

   

O6-Ethyl-deoxyguanosine

O6-Ethyl-deoxyguanosine

C12H17N5O4 (295.1280482)


   

1-Ethyl-deoxyguanosine

1-Ethyl-deoxyguanosine

C12H17N5O4 (295.1280482)


   

N2-Ethyl-deoxyguanosine

N2-Ethyl-deoxyguanosine

C12H17N5O4 (295.1280482)


   

8-Hydroxydesmethylondansetron

8-Hydroxydesmethylondansetron

C17H17N3O2 (295.1320702)


   

7-Hydroxydesmethylondansetron

7-Hydroxydesmethylondansetron

C17H17N3O2 (295.1320702)


   

6-Hydroxydesmethylondansetron

6-Hydroxydesmethylondansetron

C17H17N3O2 (295.1320702)


   

(2R,4R)-tert-butyl 4-(hydroxymethyl)-2-phenylthiazolidine-3-carboxylate

(2R,4R)-tert-butyl 4-(hydroxymethyl)-2-phenylthiazolidine-3-carboxylate

C15H21NO3S (295.12420760000003)


   

2-BENZYLOXY-3-TERT-BUTOXYCARBONYLAMINO-PROPIONIC ACID

2-BENZYLOXY-3-TERT-BUTOXYCARBONYLAMINO-PROPIONIC ACID

C15H21NO5 (295.1419656)


   

1-Piperazineaceticacid, 4-methyl-, 2-[(5-nitro-2-furanyl)methylene]hydrazide

1-Piperazineaceticacid, 4-methyl-, 2-[(5-nitro-2-furanyl)methylene]hydrazide

C12H17N5O4 (295.1280482)


   

4,6-Di-morpholin-4-yl-[1,3,5]triazine-2-carboxylic acid

4,6-Di-morpholin-4-yl-[1,3,5]triazine-2-carboxylic acid

C12H17N5O4 (295.1280482)


   

(2S,3R)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-HYDROXY-4-PHENYLBUTANOIC ACID

(2S,3R)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-HYDROXY-4-PHENYLBUTANOIC ACID

C15H21NO5 (295.1419656)


   

1-BOC-4-(4-CHLOROPHENYL)PIPERIDINE

1-BOC-4-(4-CHLOROPHENYL)PIPERIDINE

C16H22ClNO2 (295.1338982)


   

(6-ethyl-7-methoxy-5-methylimidazo[1,2-a]pyrimidin-2-yl)-phenylmethanone

(6-ethyl-7-methoxy-5-methylimidazo[1,2-a]pyrimidin-2-yl)-phenylmethanone

C17H17N3O2 (295.1320702)


   

1-HYDROXYBENZOTRIAZOLEHYDRATE

1-HYDROXYBENZOTRIAZOLEHYDRATE

C17H17N3O2 (295.1320702)


   

2-(3-OXO-1,2,3,4-TETRAHYDRO-QUINOXALIN-2-YL)-N-P-TOLYL-ACETAMIDE

2-(3-OXO-1,2,3,4-TETRAHYDRO-QUINOXALIN-2-YL)-N-P-TOLYL-ACETAMIDE

C17H17N3O2 (295.1320702)


   

(5-AMINO-2-METHOXY-PHENYL)-CARBAMICACIDTERT-BUTYLESTER

(5-AMINO-2-METHOXY-PHENYL)-CARBAMICACIDTERT-BUTYLESTER

C17H17N3O2 (295.1320702)


   

(S)-Boc-3-Methoxy-β-Phe-OH

(S)-Boc-3-Methoxy-β-Phe-OH

C15H21NO5 (295.1419656)


   

boc-(r)-3-amino-3-(2-methoxy-phenyl)-propionic acid

boc-(r)-3-amino-3-(2-methoxy-phenyl)-propionic acid

C15H21NO5 (295.1419656)


   

(R)-Boc-3-methoxy-β-Phe-OH

(R)-Boc-3-methoxy-β-Phe-OH

C15H21NO5 (295.1419656)


   

Boc-D-phe(4-OCH3)-OH

Boc-D-phe(4-OCH3)-OH

C15H21NO5 (295.1419656)


   

methyl 3-[(tert-butoxycarbonyl)amino]-3-(3-hydroxyphenyl)propanoate

methyl 3-[(tert-butoxycarbonyl)amino]-3-(3-hydroxyphenyl)propanoate

C15H21NO5 (295.1419656)


   
   

[2-(2,4-dimethoxy-phenyl)-2-oxo-ethyl]-carbamic acid tert-butyl ester

[2-(2,4-dimethoxy-phenyl)-2-oxo-ethyl]-carbamic acid tert-butyl ester

C15H21NO5 (295.1419656)


   
   

[2-(3,4-dimethoxy-phenyl)-2-oxo-ethyl]-carbamic acid tert-butyl ester

[2-(3,4-dimethoxy-phenyl)-2-oxo-ethyl]-carbamic acid tert-butyl ester

C15H21NO5 (295.1419656)


   

3-(3-PHENYLAMINO-PROPYL)-1H-QUINAZOLINE-2,4-DIONE

3-(3-PHENYLAMINO-PROPYL)-1H-QUINAZOLINE-2,4-DIONE

C17H17N3O2 (295.1320702)


   

Dexpropranolol hydrochloride

(R)-Propranolol hydrochloride

C16H22ClNO2 (295.1338982)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents (R)-Propranolol hydrochloride is a less active enantiomer of the?β-adrenoceptor antagonist?propranolol (HY-B0573). Propranolol is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1].

   
   
   

Boc-O-methyl-L-tyrosine

Boc-O-methyl-L-tyrosine

C15H21NO5 (295.1419656)


   

N-[1,1-biphenyl]-4-yl-1-naphthalenamine

N-[1,1-biphenyl]-4-yl-1-naphthalenamine

C22H17N (295.1360922)


   

Choline Citrate (1:1) (Salt)

Choline Citrate (1:1) (Salt)

C11H21NO8 (295.1267106)


   

3-N-Boc-Amino-3-(4-methoxyphenyl)propionic acid

3-N-Boc-Amino-3-(4-methoxyphenyl)propionic acid

C15H21NO5 (295.1419656)


   

Boc-beta-(S)-4-methoxyphenylalanine

Boc-beta-(S)-4-methoxyphenylalanine

C15H21NO5 (295.1419656)


   

(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-3-(2-METHOXYPHENYL)PROPANOIC ACID

(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-3-(2-METHOXYPHENYL)PROPANOIC ACID

C15H21NO5 (295.1419656)


   

Entecavir hydrate

Entecavir monohydrate

C12H17N5O4 (295.1280482)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent Entecavir monohydrate (BMS200475 monohydrate; SQ34676 monohydrate) is a potent and selective inhibitor of HBV, with an EC50 of 3.75 nM in HepG2 cell.

   

6-methyl-2,4-diphenylquinoline

6-methyl-2,4-diphenylquinoline

C22H17N (295.1360922)


   
   
   

3-(2-(BENZYLAMINO)ETHYL)QUINAZOLINE-2,4(1H,3H)-DIONE

3-(2-(BENZYLAMINO)ETHYL)QUINAZOLINE-2,4(1H,3H)-DIONE

C17H17N3O2 (295.1320702)


   

Benzeneacetonitrile, a-(3-chloropropyl)-3,4-dimethoxy-a-(1-methylethyl)-

Benzeneacetonitrile, a-(3-chloropropyl)-3,4-dimethoxy-a-(1-methylethyl)-

C16H22ClNO2 (295.1338982)


   

(2R,3R)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-HYDROXY-4-PHENYLBUTANOIC ACID

(2R,3R)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-HYDROXY-4-PHENYLBUTANOIC ACID

C15H21NO5 (295.1419656)


   

6-METHYL-4-PIPERAZINO-2-(TRIFLUOROMETHYL)QUINOLINE

6-Methyl-4-(piperazin-1-yl)-2-(trifluoromethyl)quinoline

C15H16F3N3 (295.1296252)


   

2-((TERT-BUTOXYCARBONYL)AMINO)-3-(4-METHOXYPHENYL)PROPANOIC ACID

2-((TERT-BUTOXYCARBONYL)AMINO)-3-(4-METHOXYPHENYL)PROPANOIC ACID

C15H21NO5 (295.1419656)


   

boc-(s)-3-amino-3-(2-methoxy-phenyl)-propionic acid

boc-(s)-3-amino-3-(2-methoxy-phenyl)-propionic acid

C15H21NO5 (295.1419656)


   

N-Boc-O-Benzyl-D-serine

N-Boc-O-Benzyl-D-serine

C15H21NO5 (295.1419656)


   

3-(boc-amino)-3-(3-methoxyphenyl)propionic acid

3-(boc-amino)-3-(3-methoxyphenyl)propionic acid

C15H21NO5 (295.1419656)


   
   

Propranolol hydrochloride

Propranolol hydrochloride

C16H22ClNO2 (295.1338982)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3]. Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3]. Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3].

   

4-AMINO-BENZOIC ACID 3-(1H-BENZOIMIDAZOL-2-YL)-PROPYL ESTER

4-AMINO-BENZOIC ACID 3-(1H-BENZOIMIDAZOL-2-YL)-PROPYL ESTER

C17H17N3O2 (295.1320702)


   
   

N-(tert-Butoxycarbonyl)-3-methoxy-D-phenylalanine

N-(tert-Butoxycarbonyl)-3-methoxy-D-phenylalanine

C15H21NO5 (295.1419656)


   

5-(2,1,3-benzoxadiazol-5-yl)-N-cyclopentyl-2-methylpyrimidin-4-amine

5-(2,1,3-benzoxadiazol-5-yl)-N-cyclopentyl-2-methylpyrimidin-4-amine

C16H17N5O (295.1433032)


   

Sulodexide

Adenosine, N-methyl-2-O-methyl-

C12H17N5O4 (295.1280482)


B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AB - Heparin group D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D006401 - Hematologic Agents > D000925 - Anticoagulants D009676 - Noxae > D000963 - Antimetabolites D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents D007004 - Hypoglycemic Agents

   

1,2,3-Triphenyl-1H-pyrrole

1,2,3-Triphenyl-1H-pyrrole

C22H17N (295.1360922)


   

Benzyl (2S,3aR,7aS)-octahydroindole-2-carboxylate hydrochloride

Benzyl (2S,3aR,7aS)-octahydroindole-2-carboxylate hydrochloride

C16H22ClNO2 (295.1338982)


   

(S)-(-)-PROPRANOLOL HYDROCHLORIDE

(S)-(-)-PROPRANOLOL HYDROCHLORIDE

C16H22ClNO2 (295.1338982)


(S)-(-)-Propranolol hydrochloride is a β-adrenergic receptor antagonist with log Kd?values of -8.16, -9.08, and -6.93 for β1, β2, and β3, respectively. (S)-(-)-Propranolol hydrochloride the active enantiomer of propranolol and can be s used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[2].

   

2-AMINO-1,4-DIHYDRO-4-PHENYL-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, ETHYL ESTER

2-AMINO-1,4-DIHYDRO-4-PHENYL-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, ETHYL ESTER

C17H17N3O2 (295.1320702)


   

Boc-L-Tyrosine methyl ester

Boc-L-Tyrosine methyl ester

C15H21NO5 (295.1419656)


   
   

2-Deoxy-N-ethylguanosine

2-Deoxy-N-ethylguanosine

C12H17N5O4 (295.1280482)


   

6-[4-(Methylthio)phenyl]-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline

Pyrrolo(2,1-a)isoquinoline, 1,2,3,5,6,10b-hexahydro-6-(4-(methylthio)phenyl)-, (6R,10bS)-

C19H21NS (295.13946260000006)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

O(6)-Ethyl-2-deoxyguanosine

O(6)-Ethyl-2-deoxyguanosine

C12H17N5O4 (295.1280482)


   

1-[2-(4-Phenylmethoxyphenoxy)ethyl]-1,2,4-triazole

1-[2-(4-Phenylmethoxyphenoxy)ethyl]-1,2,4-triazole

C17H17N3O2 (295.1320702)


   

furan-2-yl-[4-(1H-indol-4-yl)piperazin-1-yl]methanone

furan-2-yl-[4-(1H-indol-4-yl)piperazin-1-yl]methanone

C17H17N3O2 (295.1320702)


   

5-Methyl-2-(2-phenoxyethyl)-4-phenyl-1,2,4-triazol-3-one

5-Methyl-2-(2-phenoxyethyl)-4-phenyl-1,2,4-triazol-3-one

C17H17N3O2 (295.1320702)


   

(E)-N-benzyl-2-cyano-3-[5-(dimethylamino)furan-2-yl]prop-2-enamide

(E)-N-benzyl-2-cyano-3-[5-(dimethylamino)furan-2-yl]prop-2-enamide

C17H17N3O2 (295.1320702)


   
   

Psb 11 hydrochloride

Psb 11 hydrochloride

C16H17N5O (295.1433032)


   

2-[[(4-Ethylphenyl)-oxomethyl]amino]-4-(methylthio)butanoic acid methyl ester

2-[[(4-Ethylphenyl)-oxomethyl]amino]-4-(methylthio)butanoic acid methyl ester

C15H21NO3S (295.12420760000003)


   

4-amino-2,6-dimethyl-5-[3-(4-methylphenyl)-1H-pyrazol-5-yl]-3-pyridazinone

4-amino-2,6-dimethyl-5-[3-(4-methylphenyl)-1H-pyrazol-5-yl]-3-pyridazinone

C16H17N5O (295.1433032)


   

6-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxy-5-methyl-2,3-dihydroisoindol-1-one

6-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxy-5-methyl-2,3-dihydroisoindol-1-one

C15H21NO5 (295.1419656)


   

N-acetyl-beta-neuraminol

N-acetyl-beta-neuraminol

C11H21NO8 (295.1267106)


   

N-(2-oxolanylmethyl)-1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine

N-(2-oxolanylmethyl)-1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine

C16H17N5O (295.1433032)


   

1-(4-methylphenyl)-5-[(4-morpholinylmethylene)amino]-1H-pyrazole-4-carbonitrile

1-(4-methylphenyl)-5-[(4-morpholinylmethylene)amino]-1H-pyrazole-4-carbonitrile

C16H17N5O (295.1433032)


   

Hydron;1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;chloride

Hydron;1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;chloride

C16H22ClNO2 (295.1338982)


   
   

N,N-Dimethyladenosine

N6,N6-Dimethyladenosine

C12H17N5O4 (295.1280482)


N6,N6-Dimethyladenosine is a modified ribonucleoside previously found in rRNA, and also exhibits in mycobacterium bovis Bacille Calmette-Guérin tRNA[1].

   

PJ34

N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide

C17H17N3O2 (295.1320702)


   

Pyrrolo(2,1-a)isoquinoline, 1,2,3,5,6,10b-hexahydro-6-(4-(methylthio)phenyl)-, (6R,10bS)-

Pyrrolo(2,1-a)isoquinoline, 1,2,3,5,6,10b-hexahydro-6-(4-(methylthio)phenyl)-, (6R,10bS)-

C19H21NS (295.13946260000006)


   

(6S,10bR)-6-[4-(methylthio)phenyl]-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline

(6S,10bR)-6-[4-(methylthio)phenyl]-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline

C19H21NS (295.13946260000006)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   
   

N(6),N(6)-Dimethyladenosine

N(6),N(6)-Dimethyladenosine

C12H17N5O4 (295.1280482)


   

N6,2′-O-Dimethyladenosine

N6,2′-O-Dimethyladenosine

C12H17N5O4 (295.1280482)


N6,2′-O-Dimethyladenosine, a substrate of fat mass and obesity-associated gene (FTO), is a reversible modification widely occurred on varied RNA molecules. N6,2′-O-Dimethyladenosine can regulate obesity[1][2].

   

N6-Ethyladenosine

N6-Ethyladenosine

C12H17N5O4 (295.1280482)


N6-Ethyladenosine is an adenosine derivative, acts as a Adenosine receptor agonist, with Kis of 4.9 and 4.7 nM for hA1AR and hA3AR, respectively[1]. N6-Ethyladenosine is an adenosine derivative, acts as a Adenosine receptor agonist, with Kis of 4.9 and 4.7 nM for hA1AR and hA3AR, respectively[1].